Thursday, September 28, 2006
Sounds like Boston Scientific may end up regretting its purchase of Guidant (which they got by beating out J&J), due in part to the carried-over tort exposure due to recalled defibrillators and pacemakers. Hey, that sounds familiar.
Of course, the suits are still, I think, relatively small in number. But if Google AdSense is any indication, it might turn into a big case yet.